Europe is living through one of the most structural consolidation waves in its recent history. Between the mass succession of the German Mittelstand, the fast institutionalisation of family offices, and geopolitical pressure that is reshaping supply chains, buy-and-build is no longer a niche strategy reserved for the largest pan-European funds — it has become the shared language of an entire generation of investors, entrepreneurs and business owners. This report offers a structured read of that movement: its fundamentals, its regional specificities, its most active sectors, and the factors that separate the roll-ups that create value from those that destroy it.
Build-up and Roll-up: two strategies, one consolidation logic
The two terms are often used interchangeably, but the distinction remains useful for calibrating an investment thesis and setting investor expectations. Build-up, or buy-and-build, is a long-term construction strategy: acquire a platform company in a fragmented sector, then integrate complementary acquisitions — add-ons — with strong operational integration. The goal is to build a critical-mass player driven by real synergies, over a five-to-ten-year holding horizon.
A roll-up is a more financial, often faster variant: aggregating a large number of small companies in a fragmented sector, sometimes with light integration, primarily to capture a multiple arbitrage at exit. The horizon is shorter — three to six years — and the main value lever is the spread between the acquisition multiple paid for targets and the exit multiple of the consolidated platform. The associated risk is not integration complexity but dilution of culture and target quality.
In practice, the two approaches sit on a spectrum rather than excluding one another. In DACH, where long-term buy-and-build clearly dominates, Mittelstand founders demand a steward for their company rather than a purely financial aggregator — a pure roll-up is viewed poorly. France shows a more balanced mix, where structured funds such as Eurazeo or Ardian run disciplined build-ups while more opportunistic players pursue sector roll-ups in healthcare or services. The UK and the Nordics, more mature markets, are notably more open to pure financial roll-up — dental and veterinary DSOs remain the best-documented examples of effective light-touch integration there.
European family offices, engines of consolidation
Around 30% of European family office portfolios are now allocated to private equity, with a growing preference for direct deals over fund vehicles. These structures now account for close to a third of global direct deals done by family offices worldwide — a weight that makes them indispensable financiers of European SME consolidation.
Three dynamics are shaping this shift. First, co-investment has become the norm: 72% of European family offices now invest in secondaries, up from 60% in 2023, a sign of the appetite to deploy capital more opportunistically and faster. Second, institutionalisation is accelerating sharply — single- and multi-family offices are hiring CIOs and CFOs with private equity backgrounds and standing up formal investment committees, narrowing the sophistication gap with traditional funds. Third, generational transition is approaching fast: a third of family offices are preparing a handover within five years, and the incoming generation is markedly more oriented toward ESG and technology, which will durably reshape target selection criteria.
Four sectors driving European roll-up activity
Four broad themes account for the bulk of consolidation activity across Europe in 2026. Healthcare and med-tech is driving consolidation of dental, ophthalmology and radiology practices, with a sharp geographic arbitrage between a high-multiple Northern Europe and a Southern/Eastern Europe still offering attractive entry multiples. Green infrastructure and energy — the energy transition, data centres, storage solutions — benefit from heavy support from European public policy and rising AI-driven demand. IT services and testing, under the combined pressure of automation, cybersecurity and cloud, make MSPs (Managed Service Providers) the archetypal B2B roll-up. Finally, industry and the Mittelstand concentrate consolidation of manufacturing niches in DACH, where the succession wave is fuelling an almost inexhaustible pipeline of targets.
DACH in focus: the succession wave as a structural driver
The DACH region overtook France in 2024 to become Europe's second-largest buyout market, with 1,400 transactions recorded in H1 2025 alone, for a total volume of €83.6 billion. The structural engine behind this market remains succession: roughly 560,000 German SMEs must change ownership by 2027, close to 30% of them with no identified internal successor. Mittelstand family businesses form a steady stream of small and mid-cap transactions, and the price compression observed since 2024 is mechanically fuelling deal volume.
Deal-making here follows its own codes. The dominant approach remains succession framing: the founder is primarily seeking a steward for their company, not simply the best price. Minority stakes and partnerships are common, unlike the systematic control sought in the US, and target enterprise values typically fall between €10 million and €300 million in the lower-middle-market segment. Buy-and-build has become the reference strategy — funds such as Ufenau, Capvis, Afinum and Maxburg are structural examples — in a market where the absence of a standardised public benchmark means multiples depend heavily on sector, revenue recurrence and the competitiveness of the succession process.
The most active roll-up sectors in DACH span healthcare (dental with All Dent/Castik or Acura/Investcorp, ophthalmology with ZG Zentrum Gesundheit/Nord Holding or Sanoptis/Telemos), industry and engineering driven by post-tariff relocation, IT services under automation pressure, and renewable energy. Geopolitical pressure is not merely a risk here — it is also a catalyst: US tariffs imposed on Switzerland since 2025 create a meaningful tariff differential versus Germany, which benefits from a 15% EU tariff, pushing some Swiss SMEs to relocate within the EU or consolidate their supply chains, mechanically fuelling cross-border roll-up activity.
Switzerland in focus: geopolitical pressure and a consolidation opportunity
Switzerland counts roughly 600,000 SMEs, a significant share of them in precision engineering, medtech and B2B services — a structurally under-consolidated pool of targets. The country also ranks among the three European markets with the highest density of family offices per capita, concentrated in Geneva, Zurich and Basel, making it fertile ground for patient, well-capitalised build-up strategies.
The Swiss market has its own culture: extreme discretion, long processes of twelve to twenty-four months, and a marked preference for local or German-speaking buyers. Minority structures and partnerships are very common — a Swiss founder never sells in haste. The 2025 tariff differential, with a 15% EU tariff on Swiss exports to Germany well below the US tariffs imposed the same year, has accelerated strategic thinking among many founders. This is a genuine window of opportunity for well-positioned, culturally aligned acquirers, in a discreet but structurally rich deal-flow market where players such as BV Investment Advisors, Capvis, Invision, Zurmont Madison and Geneva/Zurich family offices remain particularly active.
France in focus: an active mid-market driven by ESG and private debt
Europe's third-largest buyout market, France posted a median mid-market multiple of 8.3× EBITDA in Q4 2025 according to the Argos index — a modest compression versus 2021–2022 that opens a favourable entry window for disciplined acquirers. The French market's distinguishing feature is the weight of ESG regulation: 67% of French institutional capital now favours Article 9 SFDR funds, making ESG a non-negotiable selection criterion for any roll-up seeking to raise from French LPs — far from a constraint, this has become a natural filter against the most opportunistic players.
Financing has also transformed profoundly: the French private debt market, estimated at €45 billion in 2025, has become the primary financing tool for mid-market LBOs, progressively substituting traditional bank debt — banks having reduced their LBO exposure since 2022 in favour of unitranche and PIK structures. France's flagship roll-up sectors span industrial maintenance, technical testing and analysis, specialised cleaning services, outpatient healthcare and B2B digital services, driven by active consolidators such as Eurazeo, Ardian, Naxicap, Bpifrance, IK Partners and Chequers Capital.
What family offices look for in a roll-up
For an entrepreneur or family office running a consolidation strategy, six criteria consistently recur among European institutional investors:
1. Track record with clear attribution — understanding why returns were generated, not just their level.
2. Genuine GP/LP alignment — a meaningful GP commitment, generally above 3% of the fund.
3. Co-investment rights — now a firm table stake, non-negotiable.
4. Credible ESG integration — 67% of French institutional capital favours Article 9 SFDR funds.
5. Proven operational capacity to scale — compliance, key-person risk management, granular reporting.
6. Tangible local presence — a manager perceived as "flying in for a single meeting" sends a strongly negative signal.
Average decision timelines run six to twelve months, ranging from three to six months in the Nordics up to twelve to eighteen months in Geneva or Southern Europe.
Sector map: the five most active roll-ups in 2026
The CIL Buy & Build Opportunity Index 2026 analysed more than 2,500 European business segments, screening for high fragmentation, scale potential and favourable market turnover. Five sectors stand out clearly by combining consolidation maturity with strong visibility on target pipelines.
Dental DSO — Europe's best-documented roll-up
The European dental market remains highly fragmented, particularly in Southern and Eastern Europe, where DSOs (Dental Support Organizations) still represent only a fraction of the market, unlike in the UK or the Netherlands. 2026 multiples range from 5–7× for a general practice, 7–10× for specialties such as orthodontics or oral surgery, up to 6.5–8.5× for a platform of more than ten sites — reaching 10–14× for super-platforms.
The value thesis combines geographic arbitrage — buying at 4–6× EBITDA in Eastern or Southern Europe to sell at 8–10× once a pan-European platform is built —, operational synergies on group purchasing and marketing, and a decisive technology gap: an independent practice cannot alone amortise a digital investment exceeding €100,000, which a DSO can pool across sites. PortmanDentex, Colosseum Dental Group, Riverdale Healthcare, All Dent/Castik and Acura/Investcorp are among the most active players.
Veterinary care — the healthcare sector's highest multiples
Veterinary consolidation is one of Europe's most active roll-ups, driven by three structural dynamics: the humanisation of pet ownership pushing spending upward, a shortage of qualified specialist vets, and active multi-platform consolidation that has pushed multiples up 4–6× since 2015. A general practice clinic now trades between 8–12× EBITDA, a specialty or emergency centre between 12–18× — among the highest valuation levels in the entire healthcare sector. IVC Evidensia (EQT), VetPartners and CVS Group are among the most prominent consolidators.
Managed IT services (MSP) — the quintessential B2B roll-up
With more than 50,000 operators in the US and a similar dynamic in Europe, the Managed Service Provider market remains one of the most fragmented in the technology sector. Multiples scale with size: 5–8× for a €1–3M EBITDA operator, 8–10× between €3M and €5M, 10–12× between €5M and €10M, and up to 12×+ for a consolidated platform. The typical deal structure combines 70% cash, 20% seller note and 10% earn-out.
The value thesis rests on three levers: the share of recurring monthly revenue, which directly lifts the multiple; cybersecurity capability, with SOC 2 or ISO 27001-certified MSPs commanding a valuation premium; and cross-selling, as an MSP acquires a cloud or cybersecurity specialist to move upmarket. ConvergeOne (CVC), Evergreen Services Group, New Era Technology and Logically (Riverside Company) are among the active European consolidators.
German industry and Mittelstand — succession as pipeline
The number that sums up the opportunity: roughly 560,000 German SMEs must change ownership by 2027, close to 30% with no identified internal successor, across sectors from technical ceramics to engineering and testing services, niche industrial subcontracting and industrial maintenance. The Argos Mid-market index stood at 8.3× in Q4 2025 — its lowest level since 2014 — opening a favourable acquisition window.
The typical structure combines succession framing, frequent minority stakes, a 20–40% rollover retained by the founder to align interests, and a 20–30% earn-out tied to post-closing performance. Ufenau, Capvis, Afinum, Maxburg, Equistone, Invision and VR Equitypartner are among the most active DACH players in this segment.
Tech-enabled home care — the technology-augmented roll-up
The 'hospital-at-home' model has become a European policy priority, epitomised by the NHS's Virtual Wards, and the sector is transitioning from a low-tech model toward high-performance care logistics. Multiples range from 5–8× for certified home care, 8–12.5× for palliative and hospice care, and 3–5× for non-medical private-duty care. The UK's Cera illustrates the thesis: acquiring traditional home care agencies and layering on a proprietary technology stack — AI-driven visit scheduling, remote monitoring, predictive analytics.
Radiology and medical imaging — capital intensity and AI
Imaging equipment — MRI, CT, PET-CT — is extremely expensive, and independent centres can neither fund upgrades nor deploy diagnostic AI on their own. Consolidated groups negotiate group purchasing rates and deploy centralised AI platforms, under an emerging hub-and-spoke model where images are acquired locally but read remotely by sub-specialists at a reference centre, sometimes in another network country. Affidea, Unilabs and Alliance Medical are among the key players in this consolidation, where diagnostic AI is the next durable differentiator against independent practices.
Financial engineering: structuring deals against high rates
With interest rates staying elevated even as they stabilise, deal structures have adapted to bridge the valuation gap between sellers still anchored to 2021 prices and buyers pricing in the reality of 2026. Four mechanisms recur consistently:
Earn-outs (20–30% of price): tied to post-closing performance, now standard in healthcare, tech, and any deal where the founder stays on.
Rollover equity / minority stakes: the seller retains 25–40% in the new entity — very common in DACH and a durable alignment tool.
Seller financing / seller notes: a below-market-rate loan from seller to buyer that reduces the need for external debt — used when the debt market is tight.
Continuation funds: transfer assets from a maturing fund into a new vehicle — particularly useful for 2018–2021 vintages reaching the end of their holding period.
Summary: five structural trends for 2026
- Mittelstand succession as a near-inexhaustible pipeline — DACH offers a structured flow of mid-sized targets, with founders motivated to sell on good terms.
- Buy-and-build as the dominant strategy — DACH funds now rarely execute deals without a complementary acquisition strategy.
- Family offices as seed and consolidation capital — high cash levels (14% of European allocations vs. 5% in the US), strong appetite for direct deals and co-investment.
- Geopolitical pressure as a consolidation accelerator — tariffs, relocation and automation are pushing SMEs to combine.
- ESG and governance as differentiators — new generations and institutionalised multi-family offices now demand institutional-grade reporting and governance.
Conclusion: three success factors for a 2026 roll-up
Recent analyses from Bain (Global Private Equity Report 2025) and EY (M&A Outlook 2026) converge on the same conclusion: Europe's outperforming roll-ups share three common traits, which are not sequential but must be present simultaneously.
The quality of the initial platform
This is factor number one. The platform must already be a profitable business, with a solid management team and scalable processes — roll-ups that fail almost always start with a platform that is too fragile. According to Bain (2025), platforms with EBITDA above €5 million and a management team already in place generate a 40% higher IRR than undersized platforms.
Pricing discipline
In a high-rate environment, every turn of multiple overpaid translates directly into value destruction. The best-performing funds in 2025 maintained strict discipline, refusing any add-on above 7× EBITDA without clearly quantified, contracted synergies. EY's M&A Outlook 2026 notes that 58% of underperforming European roll-ups had paid more than 1.5× the platform multiple for their add-ons.
The integration technology stack
This is the invisible competitive edge. Consolidators that deploy a unified ERP, centralised reporting tools and a common HR stack from the second acquisition onward cut integration costs by 30–40% on subsequent deals. By 2026, AI has become a genuine integration lever: automated reporting, financial anomaly detection, route optimisation in home care and dental.
A roll-up with an excellent platform but poor pricing discipline will ultimately destroy the value it created. The three factors — platform quality, pricing discipline, technology stack — must come together simultaneously, not sequentially.
This report was produced by Value Bridge Partners for analytical and strategic monitoring purposes. Market data is drawn from public sources and sector studies: Bain & Company, EY, McKinsey, CIL, Argos (wityu.fund), Pitchbook, Preqin, Oliver Wyman, Mergermarket, Private Equity International and specialised press. Some multiple data is indicative and may vary by specific transaction. August 2026.